Krsnaa Diagnostics Ltd | Globe Capital Market LTD.
Krsnaa Diagnostics Ltd
Price Band
Rs. 933 – 954
IPO Issue Period
Aug 04, 2021 to Aug 06, 2021
Issue Size
Rs. 1213.33 Cr.
Face value
Rs. 5/-
Fresh issue
Rs. 400 Cr.
Offer for sale
Rs. 813.33 Cr.
Minimum Shares for Retail
Maximum Shares for Retail
Listing on
Issue Type
Book Building
Tentative Listing Date
Not More than 75% of the offer
Not less than 15% of the offer
Not less than 10% of the offer
Registrar to the Issue
KFintech Private Limited

DAM Capital Advisors Ltd (Formerly IDFC Securities Ltd), Equirus Capital Private Limited, IIFL Holdings Limited, JM Financial Consultants Private Limited

Krsnaa Diagnostics Ltd is one of the fastest-growing diagnostic chains in India. The company offers a wide range of diagnostic services such as imaging/radiology services (X-rays, MRI, etc.), routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres. The firm has an extensive network of diagnostic centres across India with a key focus on non-metro, and lower tier cities and towns. As of December 31, 2020, it operates 1,801 diagnostic centres that are offering radiology and pathology services across 13 different cities in India. In fiscal 2020, the business has served 5.27 million patients. Rajendra Mutha is the promoter of the company.

For year/ period ended ( in Cr.)

31 Mar 2021 31 Mar 2020 31 Mar 2019
Total Revenue 396.46 258.43 209.24
Profit After Tax 295.45 -158.33 -77.73
EPS 71.86 -43.53 -24.13
OPM(%) 90.5% -39.2% -15.5%
PATM(%) 74.5% -61.3% -37.1%
  • Unique and scaled diagnostics company in India.
  • A comprehensive range of diagnostic services i.e. imaging, pathology, etc.
  • Strong brand equity with quality healthcare services at affordable prices.
  • Extensive footprint across India with robust infrastructure
  • It has consistent financial performance track record.
  • To finance the cost of establishing diagnostics centres at Punjab, Karnataka, Himachal Pradesh, and Maharashtra.
  • Repayment/pre-payment of firm’s borrowings fully or partially.

Krsnaa Diagnostics Ltd has posted net profits for FY21 on account of one-time gains and even with these earnings, its issue is aggressively priced at a P/E of 80+ and is thus a costly bet among listed peers. Hence, investor can subscribe to the issue for the medium to long-term.

Be a Part of IPO Success Stories!

Never Miss IPO Investment